Active, not recruitingPhase 3NCT05349214
Three-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's Syndrome
Studying Anorectal malformation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Novartis Pharmaceuticals
- Principal Investigator
- Novartis PharmaceuticalsNovartis Pharmaceuticals
- Intervention
- VAY736(biological)
- Enrollment
- 506 target
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2022 – 2027
Study locations (30)
- Providence Medical Foundation, Fullerton, California, United States
- Advanced Medical Research, La Palma, California, United States
- Bay Area Arthritis And Osteoporosis, Brandon, Florida, United States
- GNP Research, Cooper City, Florida, United States
- Sarasota Arthritis Res Ctr, Sarasota, Florida, United States
- Augusta University Georgia, Augusta, Georgia, United States
- North Georgia Rheumatology Group, Lawrenceville, Georgia, United States
- Clin Invest Specialists Inc, Orland Park, Illinois, United States
- Clinic of Robert Hozman, Skokie, Illinois, United States
- Clinical Investigation Specialists, Inc., Wauconda, Illinois, United States
- University of Kansas Hospital, Kansas City, Kansas, United States
- Tufts School of Dental Medicine, Boston, Massachusetts, United States
- Arthritis Osteoporosis Assoc of NM, Las Cruces, New Mexico, United States
- St Lawrence Health System, Potsdam, New York, United States
- On Site Clinical Solutions Llc, Charlotte, North Carolina, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05349214 on ClinicalTrials.govOther trials for Anorectal malformation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07441083Efficacy and Safety of Shatavari Root Extract in Women's Sexual WellnessSF Research Institute, Inc.
- RECRUITINGPHASE1NCT07545967Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After RadiotherapyWest China Hospital
- RECRUITINGNCT07438691Outcomes in ARMs: Comparison Between Surgical Techniques in Patients With Perineal or Vestibular Fistula - a Multicenter Italian StudyMeyer Children's Hospital IRCCS
- RECRUITINGNCT07174388A Study in Non-Small Cell Lung CancerN-Power Medicine
- RECRUITINGPHASE2NCT07311577Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing, HRD-Negative High-Risk Ovarian Cancer: A Multicenter, Non-Randomized, Single-Arm Phase II Clinical StudyJiangsu Cancer Institute & Hospital
- RECRUITINGNANCT07366476Effectiveness of Electrical Stimulation and Biofeedback on Fecal Incontinence in Children With Repaired Anorectal MalformationSinai University
- RECRUITINGPHASE2, PHASE3NCT07369739Golidocitinib Combined With Selinexor for CAEBVDBeijing Friendship Hospital
- RECRUITINGNANCT07263451Safety and Feasibility of IRE for Early-stage Breast Cancer: a Prospective, Open-Label, Single-Arm, Exploratory StudyTian'an Jiang